Bright light therapy (SAD lamp, light box)
What studies of Bright light therapy (SAD lamp, light box) found
At a glance, by condition
ME/CFS: D Little or no difference
Based on the strongest evidence, the randomised trial (very low certainty): 2 findings, all D.
2 outcomes rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: Studies found little or no difference with Bright light therapy (SAD lamp, light box) for ME/CFS. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- CMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- Bright light therapy (SAD lamp, light box) · ME/CFS is hereDLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
ME/CFS
Symptoms
Fatigue1 study · 36 people received Bright light therapy (SAD lamp, light box) Little or no difference D
Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 36 people found no clear difference; a small benefit can't be ruled out.
The randomised trial36 randomised · 2 weeks · 10,000 lux, for the course of 2 weeks
No clear difference in fatigue.
The evidence is very uncertain about the effect of bright light therapy (SAD lamp, light box) on fatigue in ME/CFS. Little or no difference · very low certainty D
- High risk of bias (RoB 2) in the results that carry most of the weight
- One trial of 36 people found no clear difference; a small benefit can't be ruled out
See the 1 study
-
- People in the study
- 36 randomised
- Dose
- 10,000 lux, for the course of 2 weeks
- Outcome
- fatigue (Chalder Fatigue Score (CFQ)) Chalder Fatigue Score (CFQ)
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- High
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
Daily life and health overall
Overall symptoms1 study · 30 people received Bright light therapy (SAD lamp, light box) Little or no difference D
Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 30 people found no clear difference; a small benefit can't be ruled out.
The randomised trial42 randomised · 30 analysed · 12 weeks · 2500 Lux, each morning for 12 weeks; for 1 h
No clear difference in overall symptoms.
The evidence is very uncertain about the effect of bright light therapy (SAD lamp, light box) on overall symptoms in ME/CFS. Little or no difference · very low certainty D
- High risk of bias (RoB 2) in the results that carry most of the weight
- One trial of 30 people found no clear difference; a small benefit can't be ruled out
See the 1 study
-
- People in the study
- 42 randomised · 30 analysed
- Dose
- 2500 Lux, each morning for 12 weeks; for 1 h
- Outcome
- principal symptoms of CFS and general measures of physical or mental health
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- High
Side effects
Stopping because of side effects1 study
Both treatments were well tolerated and not considered responsible for study withdrawals
Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy. (2002)
All papers
- Assessing fatigue in myalgic encephalomyelitis/chronic fatigue syndrome patients before and after treatment with bright light therapy: A prospective randomized controlled crossover study.2025 · randomised trial · 36 randomised
Summary
This randomized-controlled cross-over study enrolled 36 outpatients with ME/CFS according to Institute of Medicine (2015) criteria. Participants were randomly assigned to start with bright light therapy (BLT) or waitlist for 2 weeks, with a washout phase in between. BLT used portable light boxes emitting full-spectrum visible light at 10,000 lux at home. Primary outcome was fatigue on Chalder Fatigue Score (CFQ); secondary outcome was cognitive function via Test of Attentional Performance (TAP). The primary outcome fatigue was not significantly improved after BLT compared with waitlist in the full crossover design, although fatigue scores improved immediately after two weeks of BLT. Patients showed decreased reaction time after BLT in a TAP subtest compared with waitlist. Harms and withdrawals were not reported. The authors conclude BLT for two weeks is not effective for fatigue in ME/CFS but might have beneficial effects on attention. Limitations are not reported in the provided text. The trial is registered as NCT06635928.
- Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy.2002 · randomised trial · 42 randomised · 30 analysed
Summary
This randomized crossover study enrolled 42 subjects with chronic fatigue syndrome diagnosed by the Oxford criteria, identified through hospital clinics and patient groups in north-west England; 30 completed both treatment phases. Each patient was studied for 60 weeks, beginning with 12 weeks of placebo capsules, then received melatonin (5 mg capsules orally each evening for 12 weeks, 2·5 h before the median bedtime) and phototherapy (2500 Lux for 1 h each morning for 12 weeks) in random order, separated by a 12-week washout. Symptoms were measured with visual analogue scales, the Shortform (SF-36) Health Survey, Mental Fatigue Inventory and Hospital Anxiety and Depression Scale; body temperature rhythm and timing of melatonin secretion were also assessed. Neither intervention showed any significant effect on the principal symptoms or on general measures of physical or mental health. With phototherapy, sleep disturbance showed a marginal improvement (P = 0·03) and temperature phase advanced by 0·8 h (P = 0·04). With melatonin, isolated SF-36 changes were worsening of bodily pain (P = 0·044), increased vitality (P = 0·016) and improved mental health (P = 0·046), all falling short of the predetermined threshold. MFI and HAD showed no significant treatment effects. Both treatments were well tolerated and not considered responsible for study withdrawals; thirty of the 42 subjects completed both treatment phases.
- Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review.2011 · systematic review
Summary
This systematic review examined randomised controlled trials of complementary and alternative medicine (CAM) for patients with chronic fatigue syndrome (CFS), also termed myalgic encephalomyelitis (ME). The search was up to 13th August 2011. A total of 26 RCTs, which included 3,273 participants, met the inclusion criteria. The CAM therapies included mind-body medicine, distant healing, massage, tuina and tai chi, homeopathy, ginseng, and dietary supplementation. The review reports that studies of qigong, massage and tuina demonstrated positive effects, whereas distant healing failed to show a significant effect on mental or physical components of quality of life. Compared with placebo, homeopathy had insufficient evidence of symptom improvement in CFS. Most supplements failed to show beneficial effects for CFS, with the exception of NADH and magnesium. Five of the 26 included studies reported no adverse events or a slight occurrence of them, and the other included studies lacked descriptions regarding adverse events; no severe adverse effects of CAM were noted. The authors state that firm conclusions are difficult with the limited number of RCTs for each therapy, small sample sizes and high risk of bias.